What we do

We understand pharmaceutical products inside and out. We understand the science as well as the marketplace. But most of all, we understand how to communicate about a product in a way that is scientifically robust, clinically meaningful, and commercially sound.

We use this insight to engage with healthcare professionals so they can make informed decisions that enhance patients’ lives. So whatever the therapy area and wherever the market, we are able to communicate the scientific story in an intelligent and relevant way.

Our teams of highly qualified staff provide global solutions for our clients, working with the global headquarters of a wide range of pharmaceutical and biotechnology companies across Europe, the US and Asia.

Our core services include:

• Creative branding & marketing
• Digital strategy & solutions
• eLearning & training
• External expert programmes
• Healthcare strategy consulting
• Live & virtual meetings
• Medical education
• Patient engagement programmes
• Publication planning & medical writing
• Scientific PR meetings
• Strategic communications

  • Tokyo, Japan.

    Ashfield Healthcare Communications K.K.
    Hamamatsucho Building
    1-1-1 Shibaura
    Tokyo 105-0023

  • Mick O’ Leary / Regional President Commercial & Clinical Japan, Representative Director for CMIC Ashfield and Ashfield Healthcare Communications K.K.

    Mr. O’Leary studied for and received a MBA in Saint Joseph’s University in Philadelphia, USA. Joined the pharma industry as Medical Representative with Lilly in 1992, graduating to Hospital Representative in 1995.

    In 1998, he joined Pharmacia as a Hospital representative, and was soon promoted to Sales Manager. Over the next 4 years, Mr. O’Leary worked across many therapeutic areas including Neuroscience, Urology, Ophthalmology, Anti-infectives and Oncology, and ultimately became Hospital Business Manager in 2001.

    More change in 2002, when he joined Janssen as Neuroscience Business Manager to help launch Risperdal Consta. In 2005, he moved to another area of the business, this time as Business Unit Director with responsibility for Pain, Gastro and HIV.

    In 2008, Mr. O’Leary left to set up a CSO, Alchemy Healthcare. Alchemy was a CSO, with the express goal of building real partnerships with our clients in competition with Quintiles and Ashfield. It joined forces with Pharmexx in 2010, and in turn were acquired by Ashfield in 2012. Since 2013, he had been Managing Director of Ashfield Ireland and in that timeframe the company consolidated its position as Number 1 CSO with over 60% market share.

    In 2017, Mr. O’Leary was appointed as Representative Director for CMIC Ashfield and Ashfield Healthcare Communications K.K.

    Contact Mick O’ Leary at

  • Yuki Sato / Account & Business Development, Ashfield Healthcare Communications K.K.

    Mr. Yuki Sato joined the group in 2016, when Ashfield founded its Japanese agency, Ashfield Healthcare Communications K.K.
    He earned his B.S. in biochemistry and M.S. in biosciences from the University of Tokyo, Japan, and has several years’ experience of research in neurobiology.
    Prior to joining Ashfield Healthcare Communications K.K., Mr. Sato worked at Elsevier Japan K.K. as Global Key Account Manager to lead all aspects of the business with major international pharmaceutical companies in Japan.
    His previous positions also include President, Tokyo at Brand Institute, Inc., where he provided the pharmaceutical industry with regulatory expertise, strategy and best practices in brand development.
    As Director, Account & Business Development, Mr. Sato serves as key strategic contact for our clients in Japan, partnering to help develop multichannel communications programs.

    Contact Yuki Sato at

  • Dr. Edgar Ingold / VP Client Services, Physicians World Europe and Ashfield Healthcare Communications K.K.

    Dr. Edgar Ingold has been heading up Physicians World Europe since the company was founded in 1999, and is now also supporting our expansion into Japan as VP Client Services for Ashfield Healthcare Communications K.K.

    Dr Ingold holds a diploma in Biology, a Ph.D. in Plant Physiology from the University of Tübingen, Germany, and spent 2.5 years in Japan as a postdoctoral fellow.

    Prior to joining Physicians World Europe he spent 11 years at Boehringer Mannheim (now Roche), first, as Strategic Project Manager for Clinical Development, and later as head of the International Marketing department for therapeutic area Diabetes.

    Dr Ingold has extensive experience with the management of medical communication projects in a wide range of indications, including Cardiovascular Health, Diabetes, Oncology and Central Nervous System Disorders.

    Contact Dr. Edgar Ingold at

  • Healthcare and Communications /

    Ashfield Healthcare Communications K.K. is ruby sponsor of the 2nd Asia Pacific meeting of ISMPP, Tokyo, Japan

    Building on the success of the inaugural meeting last year that focused on collaboration within the region to drive ethical and effective publications, this year’s meeting will focus…

    Read more

Company Profile

Company name: アッシュフィールド・ヘルスケア・コミュニケーションズ株式会社
(Ashfield Healthcare Communications K.K. in English)

Foundation: May 2016 Legal registration
November 2016 Started business operation

Board directors: Representative Director Mick O’Leary
Director Cliff McConkey
Director Richard Lawrence

Capital: JPY 1.5 million

Registered address: Hamamatsucho Building
1-1-1 Shibaura, Minato-ku, Tokyo 105-0023

Business overview: Below items in the pharma/biotech industries
– Publication related business
– Event, meetings
– Advertising, PR, Promotion
– Branding & design
– Market research
– Consulting
– Information services

Simple Share Buttons